AI-Generated Summary

Recent child deaths in India due to contaminated cough syrups containing diethylene glycol (DEG) highlight critical failures in pharmaceutical quality control. Despite FDA bans and strict testing protocols, manufacturers are illegally using DEG as a cheap glycerin substitute, leading to severe kidney damage. This incident raises urgent concerns regarding regulatory oversight and compliance within the global pharmaceutical supply chain.

In a nutshell

This tragic series of events underscores the vital importance of robust regulatory enforcement and stringent quality assurance throughout the pharmaceutical manufacturing process. It serves as a stark reminder for industry stakeholders and policymakers to reinforce compliance to prevent future patient safety crises.

Source: Republic World